REGENXBIO Inc. - COM (RGNX)

Historical Portfolio Holders from Q3 2015 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
43.8M
Holdings value Q2 2024
$512M
Value change Q2 2024
+$8.13M
Grand Portfolio weight change Q2 2024
+0%
Number of holders
179
Number of buys Q2 2024
24
Number of sells Q2 2024
-12
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 1.39M $14.6M -$2.25M $10.49 45
2024 Q2 43.8M $512M +$8.13M $11.70 180
2024 Q1 42.3M $891M +$91.9M $21.07 183
2023 Q4 38.1M $684M +$23.7M $17.95 164
2023 Q3 36.8M $606M -$7.71M $16.46 152
2023 Q2 37.1M $742M +$3.96M $19.99 162
2023 Q1 37M $700M +$18.8M $18.91 167
2022 Q4 35.7M $809M +$5.23M $22.68 176
2022 Q3 35M $926M -$30.6M $26.43 170
2022 Q2 36.1M $893M +$28.9M $24.70 156
2022 Q1 34.9M $1.16B -$21M $33.19 178
2021 Q4 35.5M $1.16B +$58.3M $32.70 166
2021 Q3 33.4M $1.4B -$3.07M $41.92 174
2021 Q2 33.4M $1.3B +$26.8M $38.85 167
2021 Q1 32.8M $1.12B +$188M $34.11 176
2020 Q4 27.3M $1.24B -$41.7M $45.36 181
2020 Q3 28.5M $785M -$29.7M $27.52 161
2020 Q2 29.4M $1.08B +$20.1M $36.83 175
2020 Q1 28.9M $936M -$29.1M $32.38 158
2019 Q4 29.6M $1.21B -$13.2M $40.97 177
2019 Q3 29.2M $1.04B -$21.9M $35.60 163
2019 Q2 29.4M $1.51B -$22.7M $51.37 182
2019 Q1 30.1M $1.73B +$14.8M $57.31 205
2018 Q4 29.9M $1.26B +$31.7M $41.95 178
2018 Q3 28.5M $2.15B +$194M $75.50 198
2018 Q2 26M $1.87B +$332M $71.75 175
2018 Q1 22.4M $668M +$29.3M $29.85 117
2017 Q4 21.6M $718M +$5.11M $33.25 106
2017 Q3 21.4M $704M -$14.4M $32.95 87
2017 Q2 22.7M $448M +$39.1M $19.75 86
2017 Q1 20.8M $400M +$93.3M $19.30 86
2016 Q4 18.3M $339M +$28.4M $18.55 78
2016 Q3 16.9M $237M +$3.1M $14.01 71
2016 Q2 17.9M $144M +$9.9M $8.00 67
2016 Q1 16.6M $180M +$4.03M $10.80 62
2015 Q4 15M $247M -$9.92M $16.60 65
2015 Q3 14.3M $310M +$310M $22.03 47